United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $784.7M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $111.0M | 14.1% |
| Business Acquisitions | $74.7M | 9.5% |
| Other Investing | $286.7M | 36.5% |
| Other | $312.3M | 39.8% |
| Net Cash Flow | $0 | 0.0% |